These findings suggest that targeting the PRL1/USP36/Snail2 axis could potentially inhibit epithelial–mesenchymal transition (EMT) and reduce tumor invasion and metastasis, making it an attractive target for future therapeutic interventions (Figure 2B). This evidence concerns the gene PTP4A1 and neoplasm.